We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bowhead Specialty Holdings Inc | NYSE:BOW | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.68 | 1.88% | 36.84 | 37.12 | 36.39 | 36.60 | 85,024 | 22:00:00 |
Bowhead Specialty Holdings Inc. (NYSE: BOW), a growing specialty lines insurance group focused on providing casualty, professional liability and healthcare liability insurance products, today announced financial results for the second quarter ended June 30, 2024*.
Second Quarter 2024 Highlights
(1) Non-GAAP financial measure. See “—Reconciliation of Non-GAAP Financial Measures” for a reconciliation of the non-GAAP financial measures to their most directly comparable U.S. GAAP measures.
Bowhead Chief Executive Officer Stephen Sills commented, “We are very pleased with what we have to report for the results of our first quarter as a publicly traded company. We opened our doors for business as a specialty insurance underwriter in November of 2020. Over the next three plus years, we assembled a great team of over 200 employees to get us to where we are today. In May of this year, we launched an IPO to raise $100 million, which was ultimately upsized to $131 million in net proceeds. We’ve achieved our position of prominence in the specialty insurance space by building a highly experienced team focused on underwriting profitability through market cycles. We continue to believe we can attract high quality talent and generate profitable business.”
Mr. Sills continued, “Those that followed us through the IPO process will recall that almost 80% of our business is in the E&S market. The favorable market dynamics we saw then still exist today. In fact, because of the ongoing deteriorating loss experience in certain sectors and the market’s resulting need to reprice risks, we see lasting tailwinds for Bowhead, which is free of these legacy risks.”
Underwriting Results
The 50.4% increase in gross written premiums to $175.5 million in the second quarter of 2024 was driven by new business, renewals and continued growth in our platform across all divisions:
Our loss ratio of 65.5% in the second quarter of 2024 utilizes the same industry loss ratios used since the fourth quarter of 2023 and remained unchanged compared to the first quarter of 2024. There were no changes to loss picks or prior year reserves during the quarter. As of June 30, 2024, incurred but not reported liabilities comprised 92.0% of our net loss reserves.
Our expense ratio of 33.8% included $1.3 million of remaining stock-based compensation costs associated with management’s profit interest through operating expenses. Excluding this one-time increase in operating expenses, our expense ratio for the second quarter of 2024 would be 32.3%, a decrease compared to our first quarter of 2024 expense ratio of 32.6%.
Investment Results
Net investment income was $8.8 million, driven by the increase in our investment portfolio and higher yields on invested assets. Our investment portfolio included $131.0 million of net proceeds from our IPO, which were not invested for the full quarter. Excluding the net proceeds from our IPO, our investment portfolio had a book yield of 4.6% and our new money rate was 5.5% at the end of the quarter.
Excluding the net proceeds from our IPO, the weighted average effective duration of our investment portfolio, which included cash equivalents, increased from 1.9 years at March 31, 2024 to 2.1 years at June 30, 2024, and had an average rating of “AA” at June 30, 2024.
___________________* Comparisons in this release are made to June 30, 2023 financial results unless otherwise noted.
Summary of Operating Results
The following table summarizes the Company’s results of operations for the three months ended June 30, 2024 and 2023:
Three Months Ended June 30,
2024
2023
$ Change
% Change
($ in thousands, except percentages and per share data)
Gross written premiums
$
175,539
$
116,742
$
58,797
50.4 %
Ceded written premiums
(63,486)
(40,310)
(23,176)
57.5 %
Net written premiums
$
112,053
$
76,432
$
35,621
46.6 %
Revenues
Net earned premiums
$
90,087
$
61,374
$
28,713
46.8 %
Net investment income
8,777
4,048
4,729
116.8 %
Net realized investment gains
2
—
2
NM
Other insurance-related income
32
31
1
4.8 %
Total revenues
98,898
65,453
33,445
51.1 %
Expenses
Net losses and loss adjustment expenses
59,018
37,409
21,609
57.8 %
Net acquisition costs
7,582
4,960
2,622
52.9 %
Operating expenses
22,855
14,616
8,239
56.4 %
Non-operating expenses
1,481
—
1,481
NM
Warrant expense
332
—
332
NM
Credit facility interest expenses and fees
224
—
224
NM
Foreign exchange (gains) losses
(4)
8
(12)
(148.5) %
Total expenses
91,488
56,993
34,495
60.5 %
Income before income taxes
7,410
8,460
(1,050)
(12.4) %
Income tax expense
(1,877)
(1,905)
28
(1.5) %
Net income
$
5,533
$
6,555
$
(1,022)
(15.6) %
Key Operating and Financial Metrics:
Adjusted net income(1)
$
7,880
$
6,561
$
1,319
20.1 %
Loss ratio
65.5 %
61.0 %
Expense ratio
33.8 %
31.9 %
Combined ratio
99.3 %
92.8 %
Return on equity(2)
8.2 %
22.2 %
Adjusted return on equity(1)(2)
11.7 %
22.2 %
Diluted earnings per share
$
0.20
$
0.27
Diluted adjusted earnings per share(1)
$
0.28
$
0.27
__________________ NM - Percentage change is not meaningful. (1) Non-GAAP financial measure. See “—Reconciliation of Non-GAAP Financial Measures” for a reconciliation of the non-GAAP financial measures to their most directly comparable U.S. GAAP measures. (2) For the three months ended June 30, 2024 and 2023, net income and adjusted net income are annualized to arrive at return on equity and adjusted return on equity.
Condensed Consolidated Balance Sheets
June 30, 2024
December 31, 2023
($ in thousands, except share data)
Assets
Investments
Fixed maturity securities, available for sale, at fair value (amortized cost of $721,782 and $569,013, respectively)
$
706,199
$
554,624
Short-term investments, at amortized cost, which approximates fair value
12,712
8,824
Total investments
718,911
563,448
Cash and cash equivalents
180,324
118,070
Restricted cash and cash equivalents
18,494
1,698
Accrued investment income
6,728
4,660
Premium balances receivable
69,495
38,817
Reinsurance recoverable
192,025
139,389
Prepaid reinsurance premiums
133,992
116,732
Deferred policy acquisition costs
24,564
19,407
Property and equipment, net
7,481
7,601
Income taxes receivable
1,320
1,107
Deferred tax assets, net
17,071
14,229
Other assets
24,768
2,701
Total assets
$
1,395,173
$
1,027,859
Liabilities
Reserve for losses and loss adjustment expenses
$
587,905
$
431,186
Unearned premiums
391,802
344,704
Reinsurance balances payable
45,767
40,440
Income taxes payable
29
42
Accrued expenses
11,287
14,900
Other liabilities
18,472
4,510
Total liabilities
1,055,262
835,782
Commitments and contingencies (Note 13)
Mezzanine equity
Performance stock units
46
—
Stockholders' equity
Common stock
327
240
($0.01 par value; 400,000,000 shares authorized, 32,658,823 and 24,000,000 shares issued and outstanding at June 30,2024 and December 31,2023, respectively)
Additional paid-in capital
314,636
178,543
Accumulated other comprehensive loss
(12,309)
(11,372)
Retained earnings
37,211
24,666
Total stockholders' equity
339,865
192,077
Total mezzanine equity and stockholders' equity
339,911
192,077
Total liabilities, mezzanine equity and stockholders' equity
$
1,395,173
$
1,027,859
Gross Written Premiums
The following table presents gross written premiums by underwriting division for the three months ended June 30, 2024 and 2023:
Three Months ended June 30,
2024
% of Total
2023
% of Total
$ Change
% Change
($ in thousands, except percentages)
Casualty
$
114,233
65.1 %
$
63,890
54.7 %
$
50,343
78.8 %
Professional Liability
44,397
25.3 %
41,302
35.4 %
3,095
7.5 %
Healthcare
16,909
9.6 %
11,550
9.9 %
5,359
46.4 %
Gross written premiums
$
175,539
100.0 %
$
116,742
100.0 %
$
58,797
50.4 %
Loss Ratio
The following table summarizes current and prior accident loss ratios for the three months ended June 30, 2024 and 2023:
Three Months Ended June 30,
2024
2023
Net Losses and Loss Adjustment Expenses
% of Net Earned Premiums
Net Losses and Loss Adjustment Expenses
% of Net Earned Premiums
($ in thousands, except percentages)
Current accident year
$
59,018
65.5 %
$
37,148
60.5 %
Prior accident year reserve development
—
— %
261
0.4 %
Total
$
59,018
65.5 %
$
37,409
61.0 %
Expense Ratio
The following table summarizes the components of our expense ratio for the three months ended June 30, 2024 and 2023:
Three Months Ended June 30,
2024
2023
Expenses
% of Net Earned Premium
Expenses
% of Net Earned Premium
($ in thousands, except percentages)
Net acquisition costs
$
7,582
8.4 %
$
4,960
8.1 %
Operating expenses
22,855
25.4 %
14,616
23.8 %
Total expense ratio
$
30,437
33.8 %
$
19,576
31.9 %
Net Investment Income
The following table summarizes the sources of net investment income for the three months ended June 30, 2024 and 2023:
Three Months Ended June 30,
2024
2023
($ in thousands)
U.S. government and government agency
$
3,836
$
656
State and municipal
388
388
Commercial mortgage-backed securities
468
363
Residential mortgage-backed securities
1,920
246
Asset-backed securities
(33)
894
Corporate
1,071
893
Short-term investments
103
208
Cash and cash equivalents
1,204
511
Gross investment income
8,957
4,159
Investment expenses
(180)
(111)
Net investment income
$
8,777
$
4,048
Reconciliation of Non-GAAP Financial Measures
This earnings release contains certain financial measures that are not presented in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). We use these non-GAAP financial measures when planning, monitoring and evaluating our performance. Management believes that each of the non-GAAP financial measures described below provides useful insight into our underlying business performance.
You should not rely on these non-GAAP financial measures as a substitute for any U.S. GAAP financial measure. While we believe that these non-GAAP financial measures are useful in evaluating our business, this information should be considered supplemental in nature and not as a replacement for or superior to the comparable U.S. GAAP measures. In addition, other companies, including companies in our industry, may calculate such measures differently, which reduces their usefulness as comparative measures.
Adjusted net income
Adjusted net income for the three months ended June 30, 2024 and 2023 reconciles to net income as follows:
Three Months Ended June 30,
2024
2023
Before income taxes
After income taxes
Before income taxes
After income taxes
($ in thousands)
Income as reported
$
7,410
$
5,533
$
8,460
$
6,555
Adjustments:
Net realized investment gains
(2)
(2)
—
—
Non-operating expenses
1,481
1,481
—
—
Foreign exchange (gains) losses
(4)
(4)
8
8
Strategic initiatives(1)
1,496
1,496
—
—
Tax impact
—
(624)
—
(2)
Adjusted net income
$
10,381
$
7,880
$
8,468
$
6,561
___________________(1) Strategic initiatives for the three months ended June 30, 2024 represents costs incurred to set up our Baleen Specialty division, which is recorded in operating expenses within the Condensed Consolidated Statements of Income and Comprehensive Income. The costs incurred primarily represent expenses to implement the new platform and processes supporting the Baleen Specialty division. See “Business— Our Strategy”
Adjusted return on equity
Adjusted return on equity for the three months ended June 30, 2024 and 2023 reconciles to return on equity as follows:
Three Months Ended June 30,
2024
2023
($ in thousands, except percentages)
Numerator: Adjusted net income(1)
31,519
26,245
Denominator: Average mezzanine equity and stockholders' equity
270,551
118,144
Adjusted return on equity
11.7 %
22.2 %
___________________(1) For the three months ended June 30, 2024, and 2023, net income and adjusted net income are annualized to arrive at return on equity and adjusted return on equity.
Diluted adjusted earnings per share
Diluted adjusted earnings per share for the three months ended June 30, 2024 and 2023 reconciles to diluted earnings per share as follows:
Three Months Ended June 30,
2024
2023
($ in thousands, except share and per share data)
Numerator: Adjusted net income
$
7,880
$
6,561
Denominator: Diluted weighted average shares outstanding
27,771,108
24,000,000
Diluted adjusted earnings per share
$
0.28
$
0.27
About Bowhead Specialty Holdings Inc.
Bowhead Specialty is a growing specialty insurance business providing casualty and professional liability insurance products. We were founded and are led by industry veteran Stephen Sills. The team is composed of highly experienced and respected industry veterans with decades of individual, successful underwriting and management experience. We focus on providing “craft” solutions in our specialty lines and classes of business that we believe require deep underwriting and claims expertise in order to produce attractive financial results.
We pride ourselves on the quality and experience of our people, who are committed to exceeding our partners’ expectations through excellent service and expertise. Our collaborative culture spans all functions of our business and allows us to provide a consistent, positive experience for all of our partners.
Conference Call
The Company will host a conference call to discuss its results on the same day, Tuesday, August 6, 2024, beginning at 8:30 a.m. Eastern Time. Interested parties may access the conference call through a live webcast, which can be accessed via this link or by visiting the Company’s Investor Relations website, or by dialing (866) 682-6100 (toll-free) or (862) 298-0702 (international). Please join the live webcast or dial in at least 10 minutes before the start of the call.
A replay of the event webcast will be available on the company’s Investor Relations website for one year following the call.
Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical facts contained in press release are forward-looking statements. In some cases, forward-looking statements can be identified by terms such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "seeks," "future," "outlook," "prospects" "will," "would," "should," "could," "may," "can have" or similar words. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. These risks include those described under the caption "Risk Factors" in the Company's registration statement on Form S-1, Quarterly Report on Form 10-Q and other filings made with the Securities and Exchange Commission. Forward-looking statements speak only as of the date of this press release and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240806859625/en/
Investor Relations: Shirley Yap, Head of Investor Relations investorrelations@bowheadspecialty.com
1 Year Bowhead Specialty Chart |
1 Month Bowhead Specialty Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions